N = 293 | Mean ± SE | Patients (%) |
---|---|---|
Age (years) | 60.7 ± 0.7 |  |
Gender | Â | Â |
   Female |  | 44 |
   Male |  | 56 |
Smoking History | Â | Â |
   Positive |  | 53.9 |
   Negative |  | 46.1 |
ECOG | Â | Â |
   1 |  | 45.4 |
   2 |  | 23.5 |
   3 |  | 31.1 |
Clinical Stage | Â | Â |
   III B |  | 29.4 |
   IV |  | 70.6 |
Histology | Â | Â |
   Adenocarcinoma |  | 64.8 |
   *Other |  | 35.2 |
Histological Grade | Â | Â |
   Low |  | 10.3 |
   Moderate |  | 35.9 |
   High |  | 53.8 |
Metastasis at Diagnosis | Â | Â |
   CNS |  | 18.6 |
   Liver |  | 7.5 |
   **Other |  | 44.9 |
First Line Treatment | Â | Â |
   Chemotherapy |  | 87.4 |
   Tyrosine-kinase inhibitors |  | 12.6 |
EGFR*** | Â | Â |
   Positive |  | 58.6 |
   Negative |  | 41.4 |
HER2*** | Â | Â |
   Positive |  | 6.8 |
   Negative |  | 93.2 |